| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/08/2015 | US20150011541 Pipecolate-sulfonamides for treatment of psychiatric disorders |
| 01/08/2015 | US20150011538 Valaciclovir and meloxicam combination therapy for functional somatic syndromes |
| 01/08/2015 | US20150011537 Benzodiazepine compounds with anti-flavivirus activity |
| 01/08/2015 | US20150011535 Heterocyclic compounds, medicaments containing them, use and processes for the preparation thereof |
| 01/08/2015 | US20150011531 Inhibitors of hiv replication |
| 01/08/2015 | US20150011525 Solid dispersion of poorly soluble compounds comprising crospovidone and at least one water-soluble polymer |
| 01/08/2015 | US20150011522 Compounds and compositions for the treatment of parasitic diseases |
| 01/08/2015 | US20150011521 Methods for in vivo drug delivery with porous nanostructures |
| 01/08/2015 | US20150011520 Pharmaceutical compositions to reduce complications of ocular steroid |
| 01/08/2015 | US20150011518 Non-aqueous liquid composition |
| 01/08/2015 | US20150011517 Lupane triterpenoid derivatives and pharmaceutical use thereof |
| 01/08/2015 | US20150011516 Pharmaceutical compositions which inhibit fkbp52-mediated regulation of androgen receptor function and methods of using same |
| 01/08/2015 | US20150011515 Hormone Containing Emulsion |
| 01/08/2015 | US20150011514 Celecoxib Compositions |
| 01/08/2015 | US20150011512 Treatment or prophylaxis of proliferative conditions |
| 01/08/2015 | US20150011510 Substituted 4-phenyl-pyridines |
| 01/08/2015 | US20150011507 Compositions comprising lecithin oils and nsaids for protecting the gastrointestinal tract and providing enhanced therapeutic activity |
| 01/08/2015 | US20150011506 Proteasome Inhibitors |
| 01/08/2015 | US20150011504 Hydrogel compositions |
| 01/08/2015 | US20150011502 Methods and compositions to treat myocardial conditions |
| 01/08/2015 | US20150011501 Partially depolymerized glycosaminoglycan silver and gold salts |
| 01/08/2015 | US20150011500 Compositions Prepared From Poultry And Methods Of Their Use |
| 01/08/2015 | US20150011498 Use of a reduced calorie infant formula containing nucleotides and/or carotenoids for reducing adverse health effects later in life |
| 01/08/2015 | US20150011496 Methods and compositions for stimulating bone regeneration |
| 01/08/2015 | US20150011494 Therapeutic curcumin derivatives |
| 01/08/2015 | US20150011492 Anti-restenosis compositions and methods |
| 01/08/2015 | US20150011491 Treatment of papulopustular rosacea with ivermectin |
| 01/08/2015 | US20150011490 Treatment of papulopustular rosacea with ivermectin |
| 01/08/2015 | US20150011489 Treatment of inflammatory lesions of rosacea with ivermectin |
| 01/08/2015 | US20150011488 Antiviral epicatechins, epicatechin oligomers, or thiolated epicatechins from theobroma cacao for treatment of genital warts |
| 01/08/2015 | US20150011485 Combination therapy for the treatment of diabetes |
| 01/08/2015 | US20150011483 Inhibition of HIV-1 Infection by Potent Metallocene Conjugated Peptide Through Conformational Entrapment of Envelope GP120 |
| 01/08/2015 | US20150011481 Methods for Treating HCV |
| 01/08/2015 | US20150011470 N1-PYRAZOLOSPIROKETONE ACETYL-CoA CARBOXYLASE INHIBITORS |
| 01/08/2015 | US20150011463 Agent for preventing or ameliorating vascular endothelial malfunction |
| 01/08/2015 | US20150011461 Heteroaryl pyridone and aza-pyridone amide compounds |
| 01/08/2015 | US20150011006 Lentiviral triplex dna, and vectors and recombinant cells containing lentiviral triplex dna |
| 01/08/2015 | US20150011002 2,4-Pyrimidinediamine Compounds And Uses As Anti-Proliferative Agents |
| 01/08/2015 | US20150010663 Topically administered strontium-containing complexes for treating pain, pruritis and inflammation |
| 01/08/2015 | US20150010654 Methods and Compositions for Treating Mucosal Tissue Disorders |
| 01/08/2015 | US20150010651 Compositions and methods for the treatment of wounds |
| 01/08/2015 | US20150010650 Compositions comprising biomembrane sealing agent for treatment of pain or inflammation, and methods of use |
| 01/08/2015 | US20150010645 Tannin formulation for treating malnutrition |
| 01/08/2015 | US20150010643 Methods, pharmaceutical compositions, therapeutic systems, and compounds for treating b cell malignancies |
| 01/08/2015 | US20150010639 Pharmaceutical or dietary compositions based on short-chain fatty acids and complex sugars, for intestinal disorders |
| 01/08/2015 | US20150010638 Method for Improving Water Solubility of Slightly Soluble Substance |
| 01/08/2015 | US20150010637 Aqueous Suspensions of TMC278 |
| 01/08/2015 | US20150010636 Apparatus and Method for Reducing the Occurrence of Post-Surgical Adhesions |
| 01/08/2015 | US20150010633 Novel aerosol formulations of ondansetron and uses thereof |
| 01/08/2015 | US20150010632 Novel aerosol formulations of granisetron and uses thereof |
| 01/08/2015 | US20150010629 Controlled release and taste masking oral pharmaceutical composition |
| 01/08/2015 | US20150010628 Pharmaceutical composition and administrations thereof |
| 01/08/2015 | US20150010627 New pharmaceutical compositions of flurbiprofen and glucosamin |
| 01/08/2015 | US20150010626 Escalating Dosing Regimen for Effecting Weight Loss and Treating Obesity |
| 01/08/2015 | US20150010625 Low Dose Topiramate/Phentermine Composition and Methods of Use Thereof |
| 01/08/2015 | US20150010624 Carbidopa/lipodopa gastroretentive drug delivery |
| 01/08/2015 | US20150010623 Controlled release preparations |
| 01/08/2015 | US20150010622 Capsule formulation comprising fexofenadine |
| 01/08/2015 | US20150010620 Bulk Enteric Capsule Shells |
| 01/08/2015 | US20150010619 Methods and systems for treatment of migraines and other indications |
| 01/08/2015 | US20150010616 Biocompatible Particles and Method for Preparing Same |
| 01/08/2015 | US20150010614 Methods and use of inducing apoptosis in cancer cells |
| 01/08/2015 | US20150010613 Compositions and methods for cancer immunotherapy |
| 01/08/2015 | US20150010608 Therapeutic agent delivery system and method |
| 01/08/2015 | US20150010606 Intra-articular injection and implant attachment of molecule consisting of lubricin and extracellular superoxide dismutase or hyaluronic acid and extracellular superoxide dismutase |
| 01/08/2015 | US20150010603 Filler comprising beads |
| 01/08/2015 | US20150010599 Pharmaceutical formulation for reducing bladder spasms and method of use thereof |
| 01/08/2015 | US20150010585 Immunoconjugates targeting syndecan-1 expressing cells and use thereof |
| 01/08/2015 | US20150010576 Pharmaceuticals and methods for treating hypoxia and screening methods therefor |
| 01/08/2015 | US20150010574 Anti-igf antibodies |
| 01/08/2015 | US20150010570 Methods and compositions for using mhc class ii invariant chain polypeptides as a receptor for macrophage migration inhibitory factor |
| 01/08/2015 | US20150010554 Methods for treating interleukin-6 related diseases |
| 01/08/2015 | US20150010549 Methods of Treating Amyotrophic Lateral Sclerosis |
| 01/08/2015 | US20150010545 Methods for treatment of breast cancer nonresponsive to trastuzumab |
| 01/08/2015 | US20150010528 Anesthetic composition, formulation and method of use |
| 01/08/2015 | US20150010521 Prevention and treatment of cardiovascular diseases using systems and methods for transdermal nitric oxide delivery |
| 01/08/2015 | US20150010520 CoQ10 (Ubiquinone, Ubiquinol), Vitamin A (Retinoid Acid, Retinol), Vitamin E (Tocotrienol, Tocopherol) and Methods of Use |
| 01/08/2015 | US20150010511 Oil-based pharmaceutical composition for the treatment of gastrointestinal diseases |
| 01/08/2015 | US20150010509 Calcium folate (cafolate) and therapeutic methods based thereon |
| 01/08/2015 | US20150010505 Antiviral Compounds with a Dibenzooxaheterocycle Moiety |
| 01/08/2015 | US20150010504 Antiviral Compounds with a Heterotricycle Moiety |
| 01/08/2015 | US20150010503 Methods and Compositions Related to Glucocorticoid Receptor Antagonism and Prostate Cancer |
| 01/08/2015 | US20150010502 Compositions and Methods for Suppressing Gene Expression of p53 and Clusterin |
| 01/08/2015 | US20150010498 Immunocytokines for Cancer Treatment in Combination with Chemotherapeutic Agents |
| 01/08/2015 | US20150010496 Inkt cell modulators and methods of using the same |
| 01/08/2015 | US20150010491 Polyesteramide platform for site specific drug delivery |
| 01/08/2015 | US20150010479 Treatment of microbial infections |
| 01/08/2015 | US20150010475 Crlf-2 binding peptides, protocells and viral-like particles useful in the treatment of cancer, including acute lymphoblastic leukemia (all) |
| 01/08/2015 | US20150010472 Method of using adenosine and dipyridamole for pharmacologic stress testing, with specific compositions, unit dosage forms and kits |
| 01/08/2015 | US20150010471 Temporary Embolization Using Inverse Thermosensitive Polymers |
| 01/08/2015 | US20150010469 Bisphenol ether compounds with novel bridging groups and methods for their use |
| 01/08/2015 | DE202014006418U1 Canniflavon: Zytotoxizität und Wirkmechanismen in Krebszellen Canniflavon: Cytotoxicity and mechanisms of action in cancer cells |
| 01/07/2015 | EP2821504A1 Method for designating disease relating to amount of tdp-43 existing in cells |
| 01/07/2015 | EP2821488A2 Novel synthetic agonists of TLR9 |
| 01/07/2015 | EP2821407A1 Piperidinone carboxamide azaindane CGRP receptor antagonists |
| 01/07/2015 | EP2821406A1 Novel piperidine compound or salt thereof |
| 01/07/2015 | EP2821405A1 Choline esters for treating presbyopia and cataract |
| 01/07/2015 | EP2821402A1 Nitrogen-containing aromatic heterocyclic compound |
| 01/07/2015 | EP2821401A1 Heterocyclic compound and use therefor |
| 01/07/2015 | EP2821394A1 Compounds with antibacterial activity |